QSAR of aminopyrido[2,3-d]pyrimidin-7-yl derivatives: Anticancer drug design by computed descriptors

References

• Hamby JM, Connolly CJC, Schroeder MC, Winters RT, Showalter HDH, Panek RL, Major TC, Olsewski B, Ryan MJ, Dahring T, Lu GH, Keiser J, Amar A, Shen C, Kraker AJ, Slintak V, Nelson JM, Fry DW, Bradford L, Hallak H, Doherty AM. Structure-Activity Relationships for a Novel Series of Pyrido[2,3-d]pyrimidine Tyrosine Kinase Inhibitors. J Med Chem 1997; 40: 2296–2303.
   PubMed Web of Science ®Google Scholar
• Blume-Jensen P, Hunter T. Oncogenic kinase signaling. Nature 2001; 411: 355–365.
   PubMed Web of Science ®Google Scholar
• Klutchko SR, Hamby JM, Boschelli DH, Wu Z, Kraker AJ, Amar AM, Hartl BG, Shen C, Klohs WD, Steinkampf RW, Driscoll DL, Nelson JM, Elliott WL, Roberts BJ, Stoner CL, Vincent PW, Dykes DJ, Panek RL, Lu GH, Major TC, Dahring TK, Hallak H, Bradford LA, Showalter HDH, Doherty AM. 2-Substituted Aminopyrido[2,3-d]pyrimidin-7(8H)-ones. Structure-Activity Relationships Against Selected Tyrosine Kinases and in Vitro and in Vivo Anticancer Activity. J Med Chem 1998; 41: 3276–3292.
   PubMed Web of Science ®Google Scholar
• Bridges AJ, Zhou H, Sercel AD, McMichael A, Fry DW. Tyrosine Kinase Inhibitors. 16. 6,5,6-Tricyclic Benzothieno[3,2-d]pyrimidines and Pyrimido[5,4-b]- and -[4,5-b]indoles as Potent Inhibitors of the Epidermal Growth Factor Receptor Tyrosine Kinase. J Med Chem 1999; 42: 5464–5474.
   PubMedGoogle Scholar
• Schroeder MC, Hamby JM, Connolly CJC, Grohar PJ, Winters RT, Barvian MR, Moore CW, Boushelle SL, Crean SM, Kraker AJ, Driscoll DL, Vincent PW, Elliott WL, Lu GH, Batley BL, Dahring TK, Major TC, Panek RL, Doherty AM,Showalter HDH. Soluble 2-Substituted Aminopyrido[2,3-d]pyrimidin-7-yl Ureas. Structure-Activity Relationships against Selected Tyrosine Kinases and Exploration of in Vitro and in Vivo Anticancer Activity. J Med Chem 2001; 44: 1915–1926.
   PubMedGoogle Scholar
• Bagchi MC, Maiti BC, Mills D, Basak SC. Usefulness of graphical invariants in quantitative structure–activity correlations of tuberculostatic drugs of the isonicotinic acid hydrazide type. J Mol Model 2004; 10: 102–111.
   PubMedGoogle Scholar
• Bagchi MC, Maiti BC. On application of atom pairs on Drug Design. J Mol Struct: THEOCHEM 2003; 623: 31–37.
   Web of Science ®Google Scholar
• Bagchi MC, Maiti BC, Bose S. QSAR of antituberculosis drugs of INH type using graphical invariants. J Mol Struct: THEOCHEM 2004; 679: 179–186.
   Google Scholar
• Nandi S, Bagchi MC. QSAR analysis of BABQ compounds via calculated molecular descriptors. Med Chem Res 2007; 15: 393–406.
   Google Scholar
• Nandi S, Vracko M, Bagchi MC. Anticancer activity of selective phenolic compounds: QSAR studies using ridge regression and neural networks. Chem Biol Drug Des 2007; 70: 424–436.
   PubMed Web of Science ®Google Scholar
• Ghosh P, Thanadath M, Bagchi MC. On an aspect of calculated molecular descriptors in QSAR studies of quinolone antibacterials. Molecular Diversity 2006; 10: 415–427.
   PubMed Web of Science ®Google Scholar
• Hoerl AE, Kennard RW. Ridge regression biased estimation for nonorthogonal problems. Technometrics 1970; 8: 27–51.
   Google Scholar
• Ajmani S, Jadhav K, Kulkarni SA. Three-Dimensional QSAR using the k-Nearest Neighbor method and its interpretation. J Chem Inf Model 2006; 46: 24–31.
   PubMed Web of Science ®Google Scholar
• Basak SC, Mills D, Hawkins DM, EI-Masri HA. Prediction of tissue:air partition coefficient: A comparison of structure-based and property-based methods. SAR QSAR Environ Res 2002; 13: 649–665.
   PubMed Web of Science ®Google Scholar
• Basak SC, Grunwald GD Niemi GJ. In: A.T. Balaban (Ed.). From Chemical Topology To Three-Dimensional Geometry. New York: Plenum Press; 1997. p 73–116.
   Google Scholar
• http:// preadmet.brdrc.org/
   Google Scholar
• Molecular Design Suite 3.5, VLife Technologies, Pune, India. www.vlifesciences.com
   Google Scholar
• Roy K. Topological descriptors in drug design and modeling studies. Molecular Diversity 2004; 8: 321–323.
   PubMed Web of Science ®Google Scholar
• Katritzky AR, Petrukhin R, Tatham D, Basak S, Benfenati E, Karelson M, Maran U. Interpretation of quantitative structure–property and–activity relationships. J Chem Inf Comput Sci 2001; 41:679–685.
   PubMedGoogle Scholar
• Rao CR. Linear Statistical Inference and Its Applications (2nd ed.). New York: Wiley;1973.
   Google Scholar
• Randic M. Novel shape descriptors for molecular graphs. J Chem Inf Comput Sci 2001; 41: 607–613.
   PubMedGoogle Scholar
• Rencher AC, Pun FC. Inflation of R2 in best subset regression. Technometrics 1980; 22: 49–53.
   Web of Science ®Google Scholar
• Estrada E. In: J Devillers and AT Balaban (Eds.). Topological Indices And Related Descriptors In QSAR And QSPR. Amsterdam, The Netherlands: Gordon and Breach; 1999. p 403–453.
   Google Scholar
• Wold H. Soft modelling by latent variables: The non-linear iterative partial least squares approach. In: Gani J. (ed.). Perspectives in probability and statistics. papers in honor of Bartlett MS. London: Academic Press; 1975.
   Google Scholar
• Hoskuldsson A. A Combined Theory for PCA and PLS. J Chemom 1995; 9: 91–123.
   Web of Science ®Google Scholar
• Massy WF. Principal Components Regression in Exploratory Statistical Research. J. Amer Statist Assoc 1965; 60: 234–246.
   Web of Science ®Google Scholar
• Frank IE, Friedman JH. A Statistical View of Some Chemometrics Regression Tools. Technometrics 1993; 35: 109–135.
   Web of Science ®Google Scholar
• Halgren, TA. Merck Molecular Force Field. III. Molecular Geometries and Vibrational Frequencies. J Comp Chem 1996; 17: 553–586.
   Web of Science ®Google Scholar
• Cramer RD, Patterson DE, Bunce JD. Comparative molecular field analysis (CoMFA) 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 1988; 110: 5959–5967.
   PubMed Web of Science ®Google Scholar
• Gasteiger J, Marsili M. Iterative Partial Equalization of Orbital Electronegativity - A Rapid Access to Atomic Charges. Tetrahedron 1980; 36: 3219–3228.
   Web of Science ®Google Scholar
• Leach AR, Gillet VJ. An Introduction to Chemoinformatics., Boston: Kluwer Academic Publishers; 2003. p 80–100.
   Google Scholar
• Leach AR. Molecular Modelling: Principles and Applications. Henry Ling, London; 2001. p 695.
   Google Scholar
• NCSS – Statistical and Power Analysis Software; Hintze J. 2004, NCSS and PASS. Number Cruncher Statitical Systems, Kaysville, Utah. http://www.ncss.com/.
   Google Scholar
• Bagchi MC, Mills D, Basak SC. Quantitative structure-activity relationship (QSAR) studies of quinolone antibacterials against M. fortuitum and M. smegmatis using theoretical molecular descriptors. J Mol Model 2007; 13: 111–120.
   PubMed Web of Science ®Google Scholar
• Hudson BD, Hyde RM, Rahr E, Wood J. Parameter based methods for compound selection from chemical databases. Quant Struct Activity Relationships 1996; 15: 285–289.
   Google Scholar
• Kubinyi H. Ed. 3D QSAR in Drug Design. Theory, Methods and Applications. ESCOM, Leiden: Science Publishers B.V.; 1993. p 486–502.
   Google Scholar
• Samee W, Nunthanavanit P, Ungwitayatorn J. 3D-QSAR Investigation of Synthetic Antioxidant Chromone Derivatives by Molecular Field Analysis. Int J Mol Sci 2008; 9: 235–246.
   PubMed Web of Science ®Google Scholar
• Trumpp-Kallmeyer S, Rubin JR, Humblet C, Hamby JM, Showalter HDH. Development of a Binding Model to Protein Tyrosine Kinases for Substituted Pyrido[2,3-d]pyrimidine Inhibitors. J Med Chem 1998; 41: 1752–1763.
   PubMed Web of Science ®Google Scholar